WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'0801 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 6'6831 Child (under 5 years) mortality rate: 802

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'250  1'231  1'212  1'193  1'174  1'064  863  603 
Births 37  37  37  37  36  34  37  29 
Surviving infants 35  35  34  34  34  31  34  26 
Pop. less than 5 years 170  169  167  164  162  157  166  119 
Pop. less than 15 years 473  469  467  463  462  474  415  294 
Female 15-49 years 324  318  313  307  300  259  207  138 

Number of reported case

(Click for retrospective incidence data for Swaziland)
Diphtheria
Japanese encephalitis
Measles 313  26  10  1'465 
Mumps 6'773  7'602 
Pertussis 20 
Polio* 192 
Rubella 110  23  20  93  138  115 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Swaziland)
Vaccine year result method % card seen                                                
BCG          99  68  98  98  57  90  96 
DTP1          99  97  98  95  79  99* 
DTP3          98  95  91  89  72  98  89 
HepB_BD         
HepB3          98  95  91  89  72 
Hib3          98  95  91  89  72 
JapEnc         
MCV          97  88  98  94  72  80  85 
MCV2          89  52  74  96 
PCV1         
PCV3         
Pol3          98  92  85  89  68  97  89 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  61  EPI   85  72  53  79  90  94  76 
PAB         
VAD1          92  41  23  100  63 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Swaziland)
BCG 98  98  98  98  97  88  96 
DTP1 99  97  98  95  95  94  96 
DTP3 98  95  91  89  88  84  89 
HepB3 98  95  91  89  88  83 
HepB_BD
Hib3 98  95  91  89  89 
MCV 85  77  87  94  94  92  85 
MCV2 89  52  92  99  99 
PAB 86  86  86  86  86  80  63 
PCV3
Pol3 98  92  85  89  89  87  89 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
48 
   
/
|
|
\
Greater or equal to 90% 25
From 80 to 89% 0
From 50 to 79% 75
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years;
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB st contact; +1, +2 months; Health workers
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 18 months; 5 years; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From February 2014
Rotavirus From June 2015
TT 1st contact pregnancy; +1, +6 months; +1,+1 years; CBAW
VitaminA 6, 12, 18, 24, 30, 36 months;

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012 -2016  2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 25  25  100  50 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 25   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 86  100  100    100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.